Remove 2009 Remove Clinic Remove Treatment
article thumbnail

Meralgia Paresthetica: A Commonly Overlooked Cause of Thigh Pain

ChiroUp

In the next 5 minutes, heres what youll learn from this blog: A clear overview of meralgia paresthetica and its hidden causes The three most effective diagnostic tests, backed by new research Step-by-step video guides for chiropractic testing and treatment, including nerve flossing exercises to improve outcomes 1. 49,50) Imaging (e.g.,

article thumbnail

Foot Levelers Speakers Bureau welcomes two renowned experts

Chiropractic Economics

A Cleveland Chiropractic College graduate and recipient of its highest honor for clinical excellence, she blends her background in emergency medicine and sports chiropractic with a deeply compassionate, evidence-informed approach. known for her work in integrative perinatal care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

7 New Research Findings Every DC Needs to Know About Rotator Cuff Injuries

ChiroUp

If you want an even deeper dive, navigate to the home of the top chiropractic webinar and watch our advanced tutorial on When its Not the Rotator Cuff, detailing the assessment and treatment of four commonly overlooked shoulder problems. Nonetheless, we contend that providing exercise therapy should remain a principal treatment option. (14).

article thumbnail

The difference between biodentical and pharmaceutical hormones

Chiropractic Economics

The safety debate: Bioidentical versus synthetic A 2009 review in Postgraduate Medicine found patients using bioidentical hormones reported greater satisfaction and fewer side effects than those using synthetic hormones.2 Clinical considerations: It’s not one-size-fits-all Hormone therapy is not without complexity. The takeaway?

article thumbnail

ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

OrthoSpineNews

a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced it has treated the first patient in its HYDRAFIL-D FDA investigational device exemption (IDE) clinical trial for its HYDRAFIL ® System for disc augmentation. in Walnut Creek, Calif.

article thumbnail

SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales

OrthoSpineNews

This measurement is of clinical value, for example, in supporting intra-operative decisions such as the choice of bone anchors, their number, or the use of bone-reinforcing cement. It could also be useful for prescribing bone-strengthening treatments post-operatively. DSG was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D.,

article thumbnail

SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc.

OrthoSpineNews

In concrete terms, all our PediGuard devices will now be part of Omnia Medicals implant offering in a wide variety of clinical indications and spine treatment procedures, in surgical and interventional spine, in hospitals or ambulatory surgery centers. BOULDER, Co., DSG was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D.,